Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 6, 2015-06 ,pp. : 915-923

John Wiley & Sons Inc

Access to resources Recommend Favorite

Steady‐State Carbamazepine Pharmacokinetics Following Oral and Stable‐Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1627-1636

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of Integrated Radiographic Data From Two Long‐Term, Open‐Label Extension Studies of Adalimumab for the Treatment of Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 2, 2015-02 ,pp. : 180-186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials

By Janicak Philip G.   Wu Jasmanda H.   Mao Lian  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1807-1815

Informa Healthcare

Access to resources Recommend Favorite